Economic Issues in the Treatment of Benign Prostatic Hyperplasia

    September 2006 in “ European Urology Supplements ”
    Pierre Teillac, Roberto Mario Scarpa
    Studysummary Combination therapy for BPH is cost-effective, especially for men with larger prostates.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003
    2. Economic Analysis of Finasteride: A Model-Based Approach Using Data from the Proscar Long-Term Efficacy and Safety Study Clinical Therapeutics · 1999
    3. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998

    Related research 3

    1. Combined Treatment of Benign Prostatic Syndrome with Tamsulosin and Finasteride: Literature Review and Prescription Data Urologe A · 2017
    2. Analysis of Differences in Medication Adherence in the Method of Administration of Tamsulosin and Finasteride Combination Therapy for Benign Prostatic Hyperplasia 대한비뇨기종양학회지 · 2015
    3. Efficacy Observation of Tamsulosin Combined with Finasteride on Delaying and Preventing the Progression of BPH 2011